“Anyone have thoughts on this? If Cytodyn agreed
Post# of 148161
NP is an eternal narcissist and an optimist. IMO, he isn’t privy to information that we’re not in regards to this financing deal and the S/C trial data. He’s betting big on the upcoming interim analysis at 75% and does not want to raise more funds.
His comments today about suggesting to the DSMC to look earlier then 75% or right at the 293rd patient are tied to this financing deal, the amount due back to Fife per month, and how far cash on hand will go. NP said himself in the video about the financing deal last week that he hoped it would be the last deal but CYDY may need another. He wants the 75% interim analysis data ASAP so he doesn’t have to do another deal, which considering they owe $27 million to Samsung and have operating costs, may be needed as early as January or February.
Fife will get his money regardless. If you look at the annual and quarterly reports, CYDY has been paying many of these loan terms and accrued interest with shares. NP will take another loan (if needed) and use the cash for Samsung and Operating costs and use shares to pay the $7.5 million per month. Basically it’s a financing deal that’s initially money-dilutive but results in dilution as a company with no revenues uses shares to cover costs.